Clinical Trial: A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Phase II Study to Evaluate the Efficacy, Tolerability, and Safety of VBP-245 in Pediatric Subjects for the Treatment of Number of lesions from baseline to day 60 will be counted and the reduction in number will be recorded.
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Veloce BioPharma LLC
Dates:
Date Received: January 31, 2017
Date Started: February 27, 2017
Date Completion: December 2017
Last Updated: March 7, 2017
Last Verified: March 2017